- Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner Sysmex launched in EMEA and APAC territories in recent weeks - Re-design of the mTB test in progress, launch date to be announced in the next fiscal year - Discussions for the disposal of the Services business entered an exclusivity period, expect an update by the end of June - Careful cash management with a £3.9mln cash balance at the end of February, we would expect a capital raise in the second half of calendar year 2018
21 Mar 2018
Capital Network: Genedrive PLC - Interim Results for the six months to December 2017
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Capital Network: Genedrive PLC - Interim Results for the six months to December 2017
Genedrive Plc (GDR:LON) | 5.9 0 0.0% | Mkt Cap: 8.41m
- Published:
21 Mar 2018 -
Author:
Dr. Riccardo Lowi -
Pages:
3
- Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner Sysmex launched in EMEA and APAC territories in recent weeks - Re-design of the mTB test in progress, launch date to be announced in the next fiscal year - Discussions for the disposal of the Services business entered an exclusivity period, expect an update by the end of June - Careful cash management with a £3.9mln cash balance at the end of February, we would expect a capital raise in the second half of calendar year 2018